Biologic Medication Denials: How to Beat Step Therapy Requirements

Your doctor prescribed a biologic. Maybe it's for rheumatoid arthritis that's been eating away at your joints. Maybe it's for Crohn's disease that's made every meal a gamble. Maybe it's for psoriasis that covers your arms and makes you dread summer. Whatever the reason, your doctor looked at the evidence, looked at you, and decided: this is the right medication.

Then your insurance company said no. Not because the biologic isn't effective. Not because it's unsafe. But because you haven't "failed" on cheaper drugs first.

That's step therapy. And if you're reading this, it's probably standing between you and the treatment you need. Here's the good news: step therapy requirements can be challenged, overridden, and appealed. This guide will show you how.

What Is Step Therapy (and Why Does It Exist)?

Step therapy, sometimes called "fail first," is a policy that requires you to try and fail on one or more cheaper medications before your insurance company will cover the drug your doctor actually prescribed. The insurer sets the steps. You climb them. Only after you've demonstrated that the lower-cost options didn't work (or caused intolerable side effects) will they consider paying for the medication at the top of the ladder.

Insurers argue that step therapy controls costs and ensures patients try well-established treatments before moving to expensive specialty drugs. And in some cases, that logic holds up. A generic anti-inflammatory might genuinely be the right starting point. But the problem comes when the protocol ignores your specific medical history, forces you onto medications that are contraindicated, or delays treatment while your condition gets worse.

According to the American Medical Association, 93% of physicians report that prior authorization (the broader system that includes step therapy) delays necessary patient care. And 29% say it has caused a serious adverse event for a patient. Those aren't abstract numbers. They represent real people whose conditions worsened while they waited for permission to take a medicine their doctor already approved.

Which Biologics Are Affected by Step Therapy?

Almost every biologic on the market is subject to step therapy under at least some insurance plans. If you've been prescribed any of these medications, there's a good chance step therapy is part of the conversation:

• •Humira (adalimumab) and its biosimilars, used for RA, Crohn's, UC, psoriasis, and more
• •Enbrel (etanercept), commonly prescribed for RA, psoriatic arthritis, and ankylosing spondylitis
• •Dupixent (dupilumab), used for atopic dermatitis, asthma, and eosinophilic esophagitis
• •Entyvio (vedolizumab) and Stelara (ustekinumab), used for Crohn's disease and ulcerative colitis
• •Skyrizi (risankizumab), Tremfya (guselkumab), and Cosentyx (secukinumab), used for psoriasis and psoriatic arthritis
• •Xolair (omalizumab), Fasenra (benralizumab), and Nucala (mepolizumab), used for moderate-to-severe asthma

It's also worth knowing that 10 Humira biosimilars are now FDA-approved, and insurers are increasingly requiring patients to try a biosimilar before they'll cover the brand-name biologic. This adds yet another step to an already frustrating process. Biosimilars are generally effective, but the decision about which specific medication to use should be between you and your doctor, not dictated by your insurance company's formulary.

What Step Therapy Actually Looks Like by Condition

Step therapy protocols vary by insurer, but they tend to follow predictable patterns. Understanding the typical "steps" for your condition helps you know what the insurer will expect and where you can push back.

Rheumatoid Arthritis

The typical step therapy ladder for RA goes: NSAIDs (like ibuprofen or naproxen) as Step 1, then conventional DMARDs like methotrexate as Step 2, and finally biologic therapy as Step 3. Many insurers want to see documentation that you've tried methotrexate for at least 3 months before they'll approve a biologic like Humira or Enbrel. The problem? For aggressive RA, waiting months on a conventional DMARD can mean irreversible joint damage.

Psoriasis

For plaque psoriasis, step therapy usually starts with topical steroids, moves to phototherapy (light therapy), then oral systemics like methotrexate or apremilast, and only then allows biologics like Skyrizi, Tremfya, or Cosentyx. That's three full steps before you can access medications that clinical trials show are the most effective treatments available for moderate-to-severe psoriasis.

Crohn's Disease and Ulcerative Colitis

IBD step therapy typically requires aminosalicylates (like mesalamine) first, then immunomodulators (like azathioprine or 6-MP), before allowing biologics like Entyvio, Stelara, or Humira. For patients with severe disease or fistulizing Crohn's, being forced to start at Step 1 can mean months of ongoing inflammation, hospitalizations, or even surgical complications that might have been avoided with earlier biologic therapy.

Five Grounds for a Step Therapy Exception

Here's what many patients don't realize: you don't always have to climb every step. Most insurance plans, and an increasing number of state laws, recognize specific circumstances where step therapy requirements should be waived. These are the five most widely recognized grounds for a step therapy exception:

• •You've already tried and failed the required medication. If you took methotrexate two years ago and it didn't control your RA, you shouldn't have to take it again just because you switched insurance plans.
• •The required medication is contraindicated. If you have liver disease and the step therapy drug is hepatotoxic, forcing you to take it would be medically dangerous.
• •The required medication may cause irreversible harm. Some step therapy drugs carry risks of permanent side effects that, for your specific situation, outweigh any benefit.
• •You're currently stable on the prescribed medication. If you're already taking a biologic that's working and your insurer wants to switch you to a cheaper alternative, you can argue against disrupting effective treatment.
• •The required medication is not in your best interest based on clinical evidence. Your doctor can cite peer-reviewed studies showing the prescribed biologic is the better option for your specific disease presentation.

State Laws That Protect You

The legal landscape around step therapy has shifted dramatically in patients' favor. Nearly 40 states have enacted step therapy reform or override laws as of 2024 and 2025, according to the National Psoriasis Foundation. These laws give you the right to request exceptions and set deadlines for your insurer to respond.

A few notable examples: New Mexico enacted a law effective January 1, 2025, that bars step therapy entirely for autoimmune disorders, with a narrow exception for cases where a biosimilar or generic equivalent is available. New York signed step therapy reform legislation that limits how long insurers can delay access to prescribed medications. And Nebraska enacted LB1073 in 2024, adding step therapy override protections for patients in the state.

At the federal level, the Safe Step Act has been reintroduced in Congress. If passed, it would require insurers to grant step therapy exceptions within 72 hours of a request (or within 24 hours for emergencies) under the five exception circumstances listed above. The bill hasn't become law yet, but its bipartisan support signals the direction the country is moving.

How to Write a Step Therapy Exception Appeal

If your biologic was denied due to step therapy, you have the right to appeal. And the appeal doesn't have to be intimidating. Here's a practical framework you can follow:

Step 1: Get Your Denial Letter and Read It Carefully

Your Explanation of Benefits (EOB) or denial letter will state the specific reason your medication was denied and the step therapy drugs the insurer wants you to try first. It should also include instructions for how to appeal and the deadline for doing so. Read every word. The denial reason tells you exactly what argument you need to make.

Step 2: Work with Your Prescribing Doctor

Your doctor is your most powerful ally in this process. Ask them to write a letter of medical necessity that explains why the prescribed biologic is the right treatment for you and why the step therapy alternatives are inappropriate. The letter should reference your specific clinical history, failed treatments, contraindications, and relevant medical literature.

Step 3: Gather Your Evidence

A strong appeal is built on documentation. Pull together:

• •Medical records showing prior trials and failures of the required step therapy drugs
• •Lab results documenting disease severity or progression
• •Pharmacy claims or prescription history from current or previous insurers
• •Clinical notes from your physician detailing your treatment history
• •Peer-reviewed studies or clinical guidelines supporting the use of the prescribed biologic for your condition
• •Your state's step therapy override statute, if applicable

Step 4: Write Your Appeal Letter

Your letter should be clear, organized, and specific. Start with your identifying information (member ID, claim number, date of denial). State that you are requesting a step therapy exception. Identify which exception ground(s) apply: prior trial and failure, contraindication, risk of irreversible harm, stability on current therapy, or clinical evidence. Then walk through the evidence that supports each ground. Attach all supporting documentation.

Keep the tone factual and professional. You're not begging. You're making a clinical and, in many states, a legal case. If your state has a step therapy override law, cite it by name and statute number.

Step 5: Submit and Track Your Appeal

Submit your appeal by the deadline listed in your denial letter (typically 30 to 180 days, depending on your plan and state). Send it via a method that gives you proof of delivery, such as certified mail, fax with confirmation, or your insurer's secure portal. Keep copies of everything. Follow up if you don't hear back within the insurer's stated response window.

If writing the appeal yourself feels overwhelming, you're not alone. Appealio supports over 100 medications including biologics across 24 health conditions, and can help you build a structured, evidence-backed appeal letter. But whether you use a tool or go it alone, the important thing is that you file the appeal.

Clinical Evidence That Strengthens Your Appeal

Insurance companies respond to clinical evidence. The more specific and well-sourced your arguments, the harder it is for a reviewer to rubber-stamp a denial. Here are the types of evidence that carry the most weight:

• •Treat-to-target guidelines from professional medical societies (ACR for rheumatology, AAD for dermatology, AGA for gastroenterology) that support early biologic use in moderate-to-severe disease
• •Clinical trial data showing superior efficacy of the prescribed biologic compared to the step therapy alternatives for your specific condition and disease severity
• •Real-world evidence or case studies documenting disease progression or complications in patients who experienced step therapy delays
• •FDA labeling and approved indications for the prescribed medication, particularly if your condition is specifically listed
• •Your own documented disease activity scores (DAS28 for RA, PASI for psoriasis, Mayo score for UC) showing moderate-to-severe disease that warrants biologic therapy

Your doctor can help identify the most relevant clinical evidence for your situation. Many physician offices and specialty pharmacies have experience with these appeals and may have template language or citation lists they can share.

What If Your Internal Appeal Is Denied?

Don't stop. If your insurance company denies your internal appeal, you almost certainly have the right to an external review, which is an independent review by a third party who is not employed by your insurer. Under the Affordable Care Act, most health plans are required to offer external review, and the decision of the external reviewer is binding on the insurer.

External review is a powerful tool. The reviewer looks at the clinical evidence fresh, without the insurer's financial incentives. For step therapy cases with strong medical necessity arguments, external review can be the turning point. Your denial letter should include instructions for requesting one.

You can also contact your state insurance department to file a complaint, reach out to patient advocacy organizations for your condition, or ask your doctor's office about peer-to-peer review, which is a conversation between your prescribing physician and the insurer's medical director that sometimes resolves denials without a formal appeal.

The Biosimilar Wrinkle

With 10 FDA-approved Humira biosimilars now on the market, a growing number of insurers are adding a new step: try a biosimilar before the brand-name biologic. If your doctor prescribed brand-name Humira but your insurer requires you to try a biosimilar first, the appeal dynamics are a bit different. In many cases, the biosimilar is clinically equivalent, and the insurer has a reasonable basis for preferring it. But there are valid reasons to appeal even here, including stability on the brand-name drug, a history of adverse reactions to biosimilar excipients, or physician judgment about the specific clinical scenario.

If you're navigating a biosimilar-related step therapy requirement, Appealio can help you understand your options and determine whether an exception request makes sense for your situation.

You Have More Power Than You Think

Step therapy can feel like a wall between you and the treatment your doctor prescribed. But it's not a wall. It's a gate. And gates have keys.

The key is knowing your rights: the specific exception grounds that apply to your situation, the state laws that may be in your corner, and the clinical evidence that supports your doctor's prescription. The key is documentation: thorough, organized, and specific. And the key is persistence. Many step therapy denials are overturned on appeal, especially when patients come to the table prepared.

Your health is not a cost-containment exercise. If your biologic was denied, you have every right to challenge that decision. Whether you write the appeal yourself, work with your doctor's office, or use a tool to help, the most important step is the one you take next: filing that appeal.